The use of paravertebral catheters is a recommended technique to achieve postoperative analgesia after thoracic surgery. To date there is no consensus on which drug regime (local anesthetics with or without opioid) is best. The aim of this prospective clinical trial is to determine wether the use of ropivacaine and sufentanil injected through a thoracic paravertebral catheter results in decreased acute postoperative pain compared with plain ropivacaine in patients after thoracoscopic lung surgery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
90
Sufentanil at 0.25 µg/ml added to ropivacaine at 2 mg/ml at a perfusion rate of 0.15 ml/kg/h for continuous paravertebral block over 48 hours
Ropivacaine at 2 mg/ml at a perfusion rate of 0.15 ml/kg/h for continuous paravertebral block over 48 hours
Hospices Civils de Lyon, Hopital Louis Pradel, Department of Anesthesiology
Bron, France
morphine consumption during the first 48 hours
Time frame: 48 hours
Acute pain
using the Visual Analogue Scale (VAS) score
Time frame: 48 hours
Biological measurements
Oxygen saturation, level of sedation, respiratory rate, nausea, vomiting, itching, urine retention, blood pressure, heart rate
Time frame: 48 hours
Patient satisfaction
Time frame: 48 hours
Chronic pain
assessed with the Saint-Antoine Pain Questionnaire (French version of the Mac Gill Pain Questionnaire) and the DN4 questionnaire.
Time frame: 3 and 6 monthes
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.